AI assistant
Sending…
Phathom Pharmaceuticals, Inc. — Director's Dealing 2025
Mar 21, 2025
32407_dirs_2025-03-21_40a2c9a4-c7e7-4a17-84be-71a9ecc7f72c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Phathom Pharmaceuticals, Inc. (PHAT)
CIK: 0001783183
Period of Report: 2024-09-10
Reporting Person: Parikh Asit (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-09-10 | Common Stock | M | 7500 | $11.72 | Acquired | 93000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-09-10 | Stock Option (Right to Buy) | $11.72 | M | 7500 | Disposed | 2033-05-24 | Common Stock (7500) | Direct |
Footnotes
F1: The amount in column 5 shows the amount beneficially owned as of the filing date of this report.
More from Phathom Pharmaceuticals, Inc.
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Regulatory Filings
2026
Mar 27
Director's Dealing
2026
Mar 3
Annual Report
2026
Feb 26
Regulatory Filings
2026
Feb 26
Director's Dealing
2026
Feb 12